 G Protein-coupled receptors
|
|
Ion channels
|
|
Nuclear receptors
|
|
Protein kinases
|
|
 Cytokines and receptors
|
Cytokines
|
Cytokine receptors
|
Interleukin receptors
|
Interferon receptors
|
CSF and other factor receptors
|
Chemokine receptors
|
Tumor necrosis factor receptors
|
TNFRSF1 (CD120) [HSA:7132 7133] [KO:K03158 K05141]
|
TNFRSF4 (CD134, OX40) [HSA:7293] [KO:K05142]
|
TNFRSF5 (CD40) [HSA:958] [KO:K03160]
|
TNFRSF7 (CD27) [HSA:939] [KO:K05144]
|
TNFRSF8 (CD30) [HSA:943] [KO:K05145]
|
 D09587 Brentuximab vedotin (USAN/INN) <JP/US>
D04612 Iratumumab (USAN)
|
TNFRSF9 (CD137) [HSA:3604] [KO:K05146]
|
TNFRSF10A (TRAILR1, CD261) [HSA:8797] [KO:K04722]
|
TNFRSF10B (TRAILR2, CD262) [HSA:8795] [KO:K04722]
|
TNFRSF12A (TWEAKR, CD266) [HSA:51330] [KO:K05149]
|
TNFRSF13B (CD267, TACI) [HSA:23495] [KO:K05150]
|
TNFRSF13C (BAFF-R, CD268) [HSA:115650] [KO:K05151]
|
TNFRSF18 [HSA:8784] [KO:K05154]
|
NGFR (TNFRSF16, CD271) [HSA:4804] [KO:K02583]
|
TNFRSF17 (BCMA, CD269) [HSA:608] [KO:K05153]
|
Pattern recognition receptors
|
|
Cell surface molecules and ligands
|
|
Transporters
|
|
Enzymes
|
|
Nucleic acids
|
|
Not elsewhere classified
|
Signaling molecules
|
Cellular process
|
Cell cycle
|
Apoptosis
|
Membrane trafficking
|
Cytoskeleton
|
MYL2 [HSA:4633] [KO:K10351]
|
MYL3 [HSA:4634] [KO:K12749]
|
MYL4 [HSA:4635] [KO:K12750]
|
MYH6_7 [HSA:4624 4625] [KO:K17751]
|
MYH7 [HSA:4625] [KO:K17751]
|
TNNC1 [HSA:7134] [KO:K05865]
|
TNNC2 [HSA:7125] [KO:K12042]
|
TNNI2 [HSA:7136] [KO:K12043]
|
TNNI3 [HSA:7137] [KO:K12044]
|
TNNT2 [HSA:7139] [KO:K12045]
|
TNNT3 [HSA:7140] [KO:K12046]
|
DMD [HSA:1756] [KO:K10366]
|
DMD* [HSA_VAR:1756v1] [HSA:1756] [KO:K10366]
|
TUBB [HSA:10381 10382 10383 203068 347688 347733 7280 81027 84617] [KO:K07375]
|
D11691 Tirbanibulin (USAN/INN) <US>
D11692 Tirbanibulin mesylate (USAN)
D08675 Vinblastine (INN)
D01068 Vinblastine sulfate (JP18/USP) <JP/US>
D08679 Vincristine (INN)
D02197 Vincristine sulfate (JP18/USP) <JP/US>
D06304 Vindesine (USAN/INN)
D01769 Vindesine sulfate (JAN/USAN) <JP>
D08680 Vinorelbine (INN)
D01935 Vinorelbine tartrate (USP) <JP/US>
D09032 Vinflunine ditartrate (USAN)
D00491 Paclitaxel (JAN/USP/INN) <JP/US>
D07866 Docetaxel (JAN/INN) <JP/US>
D02165 Docetaxel (USP) <JP/US>
D05333 Paclitaxel poliglumex (USAN/INN)
D09755 Cabazitaxel (USAN/INN)
D10452 Cabazitaxel acetonate (JAN) <JP/US>
D04645 Ixabepilone (JAN/USAN/INN) <US>
D09980 Trastuzumab emtansine (USAN/INN) <JP/US>
D09587 Brentuximab vedotin (USAN/INN) <JP/US>
D11525 Enfortumab vedotin (USAN) <JP/US>
D11595 Belantamab mafodotin (USAN) <US>
D11814 Tisotumab vedotin (USAN/INN) <US>
D10954 Mirvetuximab soravtansine (USAN/INN) <US>
D04066 Estramustine (USAN/INN)
D02398 Estramustine phosphate sodium (USAN)
D06397 Estramustine phosphate sodium hydrate (JAN) <JP/US>
D08914 Eribulin mesylate (USAN) <JP/US>
D00570 Colchicine (JP18/USP) <JP/US>
D01919 Soblidotin (JAN/INN)
D03059 Batabulin sodium (USAN)
D03364 Cantuzumab mertansine (USAN)
D04864 Maytansine (USAN)
D05062 Mivobulin isethionate (USAN)
D06001 Taltobulin (USAN/INN)
D06009 Tasidotin hydrochloride (USAN)
D06305 Vinepidine sulfate (USAN)
D06306 Vinglycinate sulfate (USAN)
D06307 Vinleurosine sulfate (USAN)
D06308 Vinrosidine sulfate (USAN)
D06309 Vinzolidine sulfate (USAN)
D06560 Batabulin (USAN/INN)
D06576 Cevipabulin fumarate (USAN)
D08889 Cevipabulin succinate (USAN)
D09691 Vedotin (USAN)
D09912 Glembatumumab vedotin (USAN)
D09927 Lorvotuzumab mertansine (USAN/INN)
D10013 Indibulin (USAN/INN)
D10029 Verubulin (USAN/INN)
D10030 Verubulin hydrochloride (USAN)
D10073 Lexibulin (USAN)
D10454 Cantuzumab ravtansine (USAN/INN)
D11228 Soravtansine (USAN)
D11232 Denintuzumab mafodotin (USAN/INN)
D11238 Lifastuzumab vedotin (USAN/INN)
D11494 Lisavanbulin (USAN/INN)
D11681 Avanbulin (USAN/INN)
D12183 Farletuzumab ecteribulin (USAN)
D12210 Ozuriftmab vedotin (USAN)
D12220 Mecbotamab vedotin
D12310 Tusamitamab ravtansine (USAN/INN)
D12519 Sabizabulin (USAN/INN)
D12520 Sabizabulin hydrochloride (USAN)
D12582 Opadotin (USAN)
D12583 Anvatabart opadotin (USAN/INN)
|
KIF11 [HSA:3832] [KO:K10398]
|
MAPT (TAU) [HSA:4137] [KO:K04380]
|
FLNA [HSA:2316] [KO:K04437]
|
Ubiquitin system
|
Chromatin
|
Cilia formation
|
Organismal systems
|
Unclassified
|
Target-based Classification of Drugs